PExA AB (publ)
Research PExA AB (publ) (PEXA-B.ST) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerPEXA-B.ST
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Financial periodQ2 2026
- RevenueSEK 82.80K
- Net income-SEK 1.25M
- Free cash flow-SEK 3.02M
- Gross margin949.7%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 477.69K | -SEK 6.25M | -SEK 8.04M | 625.7% | -0.09 | SEK 6.24M | n/a | SEK 10.66M |
About PExA AB (publ)
PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does PExA AB (publ) do?
PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as well as parts and service kits.